Our scientific and research team
Barcode nanotech's management & researchers
CEO AND CO-FOUNDER
Ronen Eavri, Ph.D. MBA
Leading new product development in pharmaceutical and medical device companies for over 10 years (formally: J&J and D-Pharm) .
Scientific education from the Hebrew University, Technion and MIT.
CTO AND CO-FOUNDER
Annie Sabbah, Ph.D.
Former CTO of MPT Diagnostics and Lab Research Manager at Rambam Campus (Technion). Expert in microparticles and molecular biology.
Scientific education from the Technion.
R&D TEAM LEADER
Felix Badinter M.Sc.
M.Sc. in Biotechnology from the Technion.
Over 8 years of industrial experience in Research and Development in the fields of biotech and nanotechnology.
Aharon Rosenbloom Ph.D.
Ph.D. in Chemistry from Yale University
Over 10 years of experience in Chemistry/Biophysics/Biochemistry settings.
Molecular biology & Tissue analysis
Or Rosen M.Sc.
M.Sc. in Biotechnology from the Tel-Hai.
Experienced in various chemical and biological processes.
Scientific Advisory Board
Experts in nanotechnology with global experience.
INVENTOR AND CO-FOUNDER
Avi Schroeder Ph.D.
Associate Professor, Faculty of Chemical Engineering at the Technion. Prof. Schroeder is Head of the Targeted Drug Delivery and Personalized Medicine Technologies Laboratory at the Technion.
Co-founder and inventor - ViAqua Therapeutics, Moebius Medical, InPlant, and PEEL Therapeutics.
Yechezkel Barenholz Ph.D.
Professor of Biochemistry at the Hebrew University of Jerusalem. He is on the Editorial Boards of "Chemisty and Physics of Lipids" and the "Journal of Liposome Research". Prof. Barenholz has over 300 publications and over 30 patents
Inventor of the first FDA-approved liposomal medicine and founder of several prominent startups.
Medical Advisory Board
Beatrice Uziely M.D. MPH
Head, Ambulatory Services Unit, Sharett Institute of Oncology, Hadassah. She is a leading mammalogy oncologist and is one of the most well-known experts in the field of treatment of breast cancer.
Received her MD from the Hebrew Univeristy in Jerusalem.
Shai Rosenberg M.D. Ph.D.
Senior Neurologist, Neuro-Oncologist, and Head of Cancer Computational Biology Lab at Hadassah Medical Center. Expert in computational biology and cancer genomics.
M.D. and Ph.D. in statistical genetics from the Technion.
Our board members founded and managed various biotech companies.
CEO and Managing Partner of NGT3VC. Former CEO and director of Beta-O2 Technologies. Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for 11 years.
Zohar led the establishment and investment in more than 50 companies including Prolor Biotech, Mazor Robotics, ReWalk, Corindus, Regentis and many others.
Geert Cauwenbergh Ph.D.
Formally President and CEO of RXi/Phio Pharmaceuticals, founder & CEO Barrier Therapeutics and various VP roles at J&J amongst other key positions in additional pharma companies.
Stanley Hirsch Ph.D.
CEO FuturaGene. Formerly: Chairman – Foamix, Chairman-OWC Pharma; Director- Biological Industries, SolGel Technologies.
Ron Laufer M.D. MPH
Co-founder of Lilly Ventures and Senior Managing Director at Medimmune Ventures. Former Board Member of Adheron, CGI Therapeutics, G1 Therapeutics, and Remon Medical. Adjunct Professor at Kelley School of Business, Indiana University.
Ron received his M.D. and M.P.H. from the Hebrew University and his MBA from Harvard Business School.
Nili Weitzman Adv. , LLM
Chief Legal Officer at the Technion R&D Foundation for over 15 years. Specializing in intellectual property laws, leading technology transfer agreements and startups based on Technion technologies and inventions.
Nili serves as a director in the board of directors of many Technion related companies for many years.